Presentation 1: Understanding the Role of Human Epididymis Protein 4 (HE4) in Ovarian Cancer Tumorigenesis and Immune Suppression, presented by Rachael Turner, MD, PhD, Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, URMC.
Presentation 2: Role of ARID1A in the Pancreas and Pancreatic Cancer, presented by Wenjia Wang, MD, PhD, Senior Instructor in Medicine, Division of Hematology/Oncology, Department of Medicine, URMC.
At the conclusion of Presentation 1 participants should be able to:
1. Describe what is known about Human Epididymis Protein 4 (HE4).
2. Recognize that HE4 is playing a role in tumor immune suppression in ovarian cancer.
At the conclusion of Presentation 2 participants should be able to:
1. Understand the genetic and epigenetic regulation in the pathogenesis of pancreatic cancer.
2. Understand the role of ARID1A in pancreatic homeostasis and in the oncogenic transformation of pancreatic epithelium.
The University of Rochester School of Medicine and Dentistry designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Tuesday, November 26, 2019 at 12:00pm to 1:00pm
Class of '62 Auditorium
601 Elmwood Avenue, Rochester, NY 14642